Clinical Trial Update: Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding pentoxifylline to losartan reduces NT-proBNP levels more effectively than increasing the losartan dose in adults with ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Losartan (losartan)
• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Diabetic Nephropathies | Phase 4 | Status: COMPLETED